Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty

Cardiovascular disease is the leading cause of death in the US. For patients with ST-elevation myocardial infarction (STEMI), urgent reperfusion of the culprit arterial occlusion, often achieved via primary percutaneous coronary intervention (PCI), reduces post-MI mortality and other major adverse c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Ashish, Feldman, Dmitriy N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295633/
https://www.ncbi.nlm.nih.gov/pubmed/22399856
http://dx.doi.org/10.2147/VHRM.S23491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295633/
https://www.ncbi.nlm.nih.gov/pubmed/22399856
http://dx.doi.org/10.2147/VHRM.S23491

Ejemplares similares